Dusigitumab
Istiratumab
Lonigutamab
Robatumumab
Dalotuzumab
Ganitumab
Xentuzumab
Cixutumumab
Figitumumab
Teprotumumab
Veligrotug
IGF-I (30-41) (TFA)
IGF-I (24-41) (TFA)
IGF-I (24-41)
Chimaphilin
Sorbic acid
AZ7550 hydrochloride
AZ7550-d 5
AZ7550 Mesylate
AZ7550